Karl Saardi is a Dermatology physician affiliated with George Washington University. OpenAlex indexes 25 publications with 456 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2150 Pennsylvania Ave NW Ste 2b-430
Washington, DC 200373201
Telephone
202-741-3000Provider last certified this registry record 30 Jun 2020.
Industry payments
37 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20259 payments
- Janssen Biotech, Inc.Program year20254 payments
- ABBVIE INC.Program year202512 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
34.7%Corticosteroid16.2%Triamcinolone Acetonide78%Triamcinolone acetonide22%Part D + Part B≥44 patientsInterleukin-4 Receptor alpha Antagonist11.1%Dupixent Pen100%Part D≥15 patients+ 3 more classes in this area
Cancer & immunology
26.2%Interleukin-17A Antagonist8.6%Cosentyx Unoready Pen75%Taltz Autoinjector25%Part D<11 patientsTNF inhibitor7.6%Humira(Cf) Pen39%Humira Pen31%Remicade31%Part D<11 patients+ 3 more classes in this area
Sensory organs
13.3%Corticosteroid13.3%Clobetasol Propionate70%Hydrocortisone16%Dexamethasone14%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 0412 Discoid lupus erythematosus rapidly responsive to deucravacitnib
Journal of Investigative Dermatology
2025 - 63313 Case Series: Cutaneous Metastasis Masquerading as Hidradenitis Suppurativa
Journal of the American Academy of Dermatology
2025 - Cutaneous Metastases Mimicking Hidradenitis Suppurativa: A Diagnostic Challenge
WOUNDS A Compendium of Clinical Research and Practice
2025 - Erythrodermic Bullous Pemphigoid in Skin of Color Treated With Dupilumab
Journal of Drugs in Dermatology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Cynthia Tracy, MD
George Washington University
Paul Kimmel, MD
George Washington University
William Borden, MD
George Washington University
Dominic Raj, MD
George Washington University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”